| ²é¿´: 1659 | »Ø¸´: 7 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
³Ôɶ×Ó³Ô°¡Ð³æ (³õÈëÎÄ̳)
|
[ÇóÖú]
ÇóάÀ×ôͪ£¨Vilazodone£©ÔÓÖʵÄÎÄÏ×±¨µÀ
|
|
|
Ò©Æ·»ù±¾ÐÅÏ¢ÈçÏ£º ¡¡ÖÐÎÄÃû³Æ£ºÎ¬À×ôͪ Ó¢ÎÄÃû³Æ Vilazodone ¡¡¡¡ Ó¢ÎıðÃû 5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2- carboxamide ¡¡¡¡ CAS NO. 163521-12-8 2011Äê1ÔÂ21ÈÕÅú×¼ÑÎËáάÀ×ôͪ£¨ÉÌÆ·ÃûViibryd£©Æ¬¼ÁÓÃÓÚÖÎÁƳÉÈËÖØ¶ÈÒÖÓôÖ¢¡£ ÇóÖú¸ÃÒ©µÄÔÓÖʱ¨µÀµÄÎÄÏ×»òÕßרÀû£¡Ð»Ð»! |
» ²ÂÄãϲ»¶
2025ÄêҩѧרҵÇóµ÷¼Á
ÒѾÓÐ1È˻ظ´
ҩѧÇóµ÷¼Á£¬±¾¿ÆÓÐÂÛÎÄ£¬£¨²ÄÁÏ¡¢ÉúÎ﹤³Ì¡¢ÉúÎïÓëÒ½Ò©¶¼¿ÉÒÔ£©
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ69È˻ظ´
£¨1055£©ÇóҩѧBÇøµ÷¼Á
ÒѾÓÐ0È˻ظ´
Ôð±àһֱûÓиø¶¯¾² ÊÇÁ¹ÁËÂð
ÒѾÓÐ20È˻ظ´
ºÓ±±Ò½¿Æ´óѧҩѧÏà¹Ø×¨Òµ½ÓÊܵ÷¼Á
ÒѾÓÐ20È˻ظ´
¡¾ÕÐÆ¸¡¿Ç廪´óѧҩѧԺǮ·æ½ÌÊÚ¿ÎÌâ×é³ÏƸ²©Ê¿ºó
ÒѾÓÐ1È˻ظ´
аæscifinder
ÒѾÓÐ1È˻ظ´
°²½ÝÂ×ÒºÏàÉ«Æ×ÖùÓë·½·¨¿ª·¢Ö¸ÄÏ
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
´ó¼ÒÀ´ÌÖÂÛÏÂÖÆ±¸´ß»¯¼ÁÈçºÎɸѡÖú¼Á£¬½»Á÷ϹØÓÚÖú¼Á±È½ÏºÃµÄÎÄÏ×Êé¼®µÈ
ÒѾÓÐ13È˻ظ´
²âÐòÕýÈ·µÄÖÊÁ£ÓÃSfiIøÇв»¶¯£¬ÇëÎÊÓÐʲôÏà¹ØÎÄÏ×Âð
ÒѾÓÐ6È˻ظ´
ÈçºÎÅàÑø¿´Íâ¹úÎÄÏ×µÄÄÜÁ¦
ÒѾÓÐ23È˻ظ´
¹ÌÏàÝÍÈ¡ÖùÔõôÄÇô¶àÔÓÖʰ¡£¿
ÒѾÓÐ12È˻ظ´
¶þàçßòÁòͪµÄ½á¹¹Çø·Ö
ÒѾÓÐ15È˻ظ´
ÖйúÒ³ÑÒÆøÊ×´Îˮƽ¾®Ñ¹ÁÑ À¿ªÐòÄ»--ÖÐÑëÐÂÎű¨µÀÊÓÆµ
ÒѾÓÐ8È˻ظ´
Ͷsyn. comm.ÂíÉϱ»unsubmitted, ÎÒ¾õµÃÎÒ¸ÃÄܵÄÊý¾ÝÎÄÏ×¶¼¸øÆëÁËѽ£¬Ôõô»ØÊÂ
ÒѾÓÐ6È˻ظ´
¡¾ÇóÖú¡¿L-±½±û°±ËáºÍÈý¹âÆøµÄÒ»°ãÓõķ´Ó¦ÈܼÁÊÇʲô£¬×îºÃÄÜÌṩһƪ±¨µÀÎÄÏ×
ÒѾÓÐ4È˻ظ´
¡¾ÌÖÂÛ¡¿°ëµ¼ÌåSiCµÄ½û´ø¿í¶ÈÒ²ÊʺϹâ½âË®£¬ÔõôûÓмûÏà¹ØµÄÎÄÏ×±¨µÀ°¡£¿Çó½âÖС£¡£¡
ÒѾÓÐ38È˻ظ´
¡¾ÇóÖú¡¿AgµÄXPSΪʲô±ÈÎÄÏ×±¨µÀµÄµÍÄØ£¿
ÒѾÓÐ10È˻ظ´
¡¾ÇóÖú¡¿ÇóÖú±½¼×ËáºÍÒÒËáΪÔÁÏÖÆ±¸±½ÒÒͪµÄÎÄÏ×»ò·½·¨
ÒѾÓÐ5È˻ظ´
³Ôɶ×Ó³Ô°¡
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 160.8
- Ìû×Ó: 48
- ÔÚÏß: 14.7Сʱ
- ³æºÅ: 1064599
- ×¢²á: 2010-07-26
- רҵ: ÓлúºÏ³É
5Â¥2012-06-15 10:53:24
wojiushiyao
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 3482.3
- Ìû×Ó: 284
- ÔÚÏß: 139.8Сʱ
- ³æºÅ: 256651
- ×¢²á: 2006-06-03
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
2Â¥2012-06-12 16:54:39
³Ôɶ×Ó³Ô°¡
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 160.8
- Ìû×Ó: 48
- ÔÚÏß: 14.7Сʱ
- ³æºÅ: 1064599
- ×¢²á: 2010-07-26
- רҵ: ÓлúºÏ³É
3Â¥2012-06-13 10:03:10
wojiushiyao
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 3482.3
- Ìû×Ó: 284
- ÔÚÏß: 139.8Сʱ
- ³æºÅ: 256651
- ×¢²á: 2006-06-03
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
³Ôɶ×Ó³Ô°¡: ½ð±Ò+6, ¡ï¡ï¡ïºÜÓаïÖú 2012-06-18 13:35:51
³Ôɶ×Ó³Ô°¡: ½ð±Ò+6, ¡ï¡ï¡ïºÜÓаïÖú 2012-06-18 13:35:51
|
www.accessdata.fda.gov/.../022567Orig1s000SumR.pdf M E M O R A N D U M DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH DATE: January 18, 2011 FROM: Thomas P. Laughren, M.D. Director, Division of Psychiatry Products HFD-130 SUBJECT: Recommendation for approval action for vilazodone tablets as a treatment for major depressive disorder (MDD). TO: File NDA 22-567 [Note: This overview should be filed with the 3-22-10 original submission of this NDA.] |
4Â¥2012-06-13 14:22:35













»Ø¸´´ËÂ¥